<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Adv</journal-id><journal-id journal-id-type="iso-abbrev">Sci Adv</journal-id><journal-id journal-id-type="publisher-id">SciAdv</journal-id><journal-id journal-id-type="hwp">advances</journal-id><journal-title-group><journal-title>Science Advances</journal-title></journal-title-group><issn pub-type="epub">2375-2548</issn><publisher><publisher-name>American Association for the Advancement of Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7299625</article-id><article-id pub-id-type="publisher-id">abb5813</article-id><article-id pub-id-type="doi">10.1126/sciadv.abb5813</article-id><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group><subj-group subj-group-type="legacy-article-type"><subject>SciAdv r-articles</subject></subj-group><subj-group subj-group-type="overline"><subject>Coronavirus</subject></subj-group></article-categories><title-group><article-title>Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-1419-717X</contrib-id><name><surname>Di Giorgio</surname><given-names>Salvatore</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="afn1">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0001-7564-9224</contrib-id><name><surname>Martignano</surname><given-names>Filippo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="afn1">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0003-4740-4646</contrib-id><name><surname>Torcia</surname><given-names>Maria Gabriella</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-9668-1706</contrib-id><name><surname>Mattiuz</surname><given-names>Giorgio</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="author-notes" rid="afn2">&#x02020;</xref><xref rid="cor1" ref-type="corresp">&#x02021;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-4244-1846</contrib-id><name><surname>Conticello</surname><given-names>Silvestro G.</given-names></name><xref ref-type="award" rid="award595388"/><xref ref-type="award" rid="award595389"/><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="author-notes" rid="afn2">&#x02020;</xref><xref rid="cor1" ref-type="corresp">&#x02021;</xref></contrib><aff id="aff1"><label>1</label>Core Research Laboratory, ISPRO, Firenze 50139, Italy.</aff><aff id="aff2"><label>2</label>Department of Medical Biotechnologies, University of Siena, Siena 53100, Italy.</aff><aff id="aff3"><label>3</label>Department of Experimental and Clinical Medicine, University of Florence, Firenze 50139, Italy.</aff><aff id="aff4"><label>4</label>Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.</aff></contrib-group><author-notes><fn id="afn1" fn-type="equal"><label>*</label><p>These authors contributed equally to this work.</p></fn><fn id="afn2" fn-type="equal"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn><corresp id="cor1"><label>&#x02021;</label>Corresponding author. Email: <email xlink:href="giorgio.mattiuz@unifi.it">giorgio.mattiuz@unifi.it</email> (G.M.); <email xlink:href="s.conticello@ispro.toscana.it">s.conticello@ispro.toscana.it</email> (S.G.C.)</corresp></author-notes><pub-date pub-type="collection"><month>6</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>17</day><month>6</month><year>2020</year></pub-date><volume>6</volume><issue>25</issue><elocation-id>eabb5813</elocation-id><history><date date-type="received"><day>04</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>05</day><month>5</month><year>2020</year></date><date date-type="epub"><day>18</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Authors</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" id="p-2"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial license</ext-link>, which permits use, distribution, and reproduction in any medium, so long as the resultant use is <bold>not</bold> for commercial advantage and provided the original work is properly cited.</license-p></license></permissions><abstract abstract-type="teaser"><p>Host deaminases shape the viral RNA genome and its evolution by targeting its RNA.</p></abstract><abstract><p>The COVID-19 outbreak has become a global health risk, and understanding the response of the host to the SARS-CoV-2 virus will help to combat the disease. RNA editing by host deaminases is an innate restriction process to counter virus infection, but it is not yet known whether this process operates against coronaviruses. Here, we analyze RNA sequences from bronchoalveolar lavage fluids obtained from coronavirus-infected patients. We identify nucleotide changes that may be signatures of RNA editing: adenosine-to-inosine changes from ADAR deaminases and cytosine-to-uracil changes from APOBEC deaminases. Mutational analysis of genomes from different strains of Coronaviridae from human hosts reveals mutational patterns consistent with those observed in the transcriptomic data. However, the reduced ADAR signature in these data raises the possibility that ADARs might be more effective than APOBECs in restricting viral propagation. Our results thus suggest that both APOBECs and ADARs are involved in coronavirus genome editing, a process that may shape the fate of both virus and patient.</p></abstract><funding-group><award-group id="award595388"><funding-source><institution-wrap><institution-id institution-id-type="doi">http://dx.doi.org/10.13039/501100003196</institution-id><institution>Ministero della Salute</institution></institution-wrap></funding-source><award-id>PE-2013-02357669</award-id></award-group><award-group id="award595389"><funding-source><institution-wrap><institution-id institution-id-type="doi">http://dx.doi.org/10.13039/501100005010</institution-id><institution>Associazione Italiana per la Ricerca sul Cancro</institution></institution-wrap></funding-source><award-id>IG-17701</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>Copyeditor</meta-name><meta-value>Kyle Solis</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="introduction" disp-level="1"><title>INTRODUCTION</title><p>Emerging viral infections represent a threat to global health, and the recent outbreak of novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, novel coronavirus, 2019-nCoV) exemplifies the risks (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>, <xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). As viruses are obligate intracellular parasites, organisms have evolved innate immune mechanisms to sense and counter the viruses. Among these mechanisms, RNA and DNA editing mediated by endogenous deaminases can provide a potent defense against specific viruses. Two deaminase families are present in mammalian species: The ADARs (adenosine deaminases that act on RNA) target double-stranded RNA (dsRNA) for deamination of adenines into inosines (A-to-I) (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>, <xref rid="R4" ref-type="bibr"><italic>4</italic></xref>), and the APOBECs deaminate cytosines into uracils (C-to-U) on single-stranded nucleic acids [single-stranded DNA (ssDNA) and single-stranded RNA (ssRNA)] (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>, <xref rid="R6" ref-type="bibr"><italic>6</italic></xref>). During viral infections, ADARs act either directly, through hypermutation of the viral RNA, or indirectly, through editing of host transcripts that modulate the cellular response (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>&#x02013;<xref rid="R18" ref-type="bibr"><italic>18</italic></xref>). On the other hand, APOBECs target the viral genome, typically DNA intermediates (<xref rid="R19" ref-type="bibr"><italic>19</italic></xref>&#x02013;<xref rid="R26" ref-type="bibr"><italic>26</italic></xref>), either through C-to-U hypermutation or through a non-enzymatic path that interferes with reverse transcription (<xref rid="R27" ref-type="bibr"><italic>27</italic></xref>, <xref rid="R28" ref-type="bibr"><italic>28</italic></xref>). Although some APOBEC3 proteins can interfere in vitro with Coronaviridae replication, it is not clear whether their enzymatic activity is involved (<xref rid="R29" ref-type="bibr"><italic>29</italic></xref>). Ultimately, though, these restriction systems can also be exploited by the viruses to support their infectivity and increase their evolutionary potential (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>, <xref rid="R11" ref-type="bibr"><italic>11</italic></xref>&#x02013;<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>, <xref rid="R30" ref-type="bibr"><italic>30</italic></xref>&#x02013;<xref rid="R32" ref-type="bibr"><italic>32</italic></xref>).</p></sec><sec sec-type="results" disp-level="1"><title>RESULTS</title><p>To assess whether RNA editing could be involved in human host responses to SARS-CoV-2 infections, we started from publicly available RNA sequencing datasets from bronchoalveolar lavage fluids (BALF) obtained from patients diagnosed with COVID-19. While transcriptomic data for all samples could be aligned to the SARS-CoV-2 reference genome, the quality of the sequencing varied and only eight samples had coverage and error rates suitable for the identification of potentially edited sites (data S1). We called single-nucleotide variants (SNVs) on these eight samples (<xref rid="R33" ref-type="bibr"><italic>33</italic></xref>, <xref rid="R34" ref-type="bibr"><italic>34</italic></xref>) using REDItools 2 (<xref rid="R35" ref-type="bibr"><italic>35</italic></xref>&#x02013;<xref rid="R37" ref-type="bibr"><italic>37</italic></xref>) and JACUSA (<xref rid="R38" ref-type="bibr"><italic>38</italic></xref>) using the following thresholds: reads supporting the SNV &#x02265;4, allelic fraction &#x02265;0.5%, coverage &#x02265;20, quality of the reads &#x0003e;25, base quality &#x0003e;35 (fig. S1A). The two pipelines gave comparable results with ~50% of the SNV positions called by both (figs. S1B and S2). We identified 910 SNVs common to REDItools 2 and JACUSA, ranging from 24 to 238 SNVs per sample (<xref rid="F1" ref-type="fig">Fig. 1</xref> and data S3). Given the thresholds used to call the SNV, samples with lower sequencing depths displayed lower numbers of SNVs.</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>SNVs identified in SARS-CoV-2 transcriptomes.</title><p>The bar charts show the number of SNVs identified in each SARS-CoV-2 transcriptome for each SNV type (e.g., A&#x0003e;C, AC). The sequencing depth for each sample is indicated.</p></caption><graphic xlink:href="abb5813-F1"/></fig><p>While the weight of each SNV type varies across samples (<xref rid="F1" ref-type="fig">Fig. 1</xref>), a bias toward transitions is always present, which is even more evident when all mutational data are pooled (<xref rid="F2" ref-type="fig">Fig. 2, A and B</xref>). This pattern holds true even when only SNVs recurring in more samples are considered (<xref rid="F2" ref-type="fig">Fig. 2C</xref>).</p><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>SNV identified in SARS-CoV-2 transcriptomes.</title><p>(<bold>A</bold>) Allelic fraction and (<bold>B</bold>) number of SNVs for each nucleotide change in the entire dataset and (<bold>C</bold>) for SNVs recurring in at least two samples. (<bold>D</bold>) Distribution of SNVs across the SARS-CoV-2 genome. A-to-G (blue) and C-to-U (red) SNVs are grouped in 400-nucleotide (nt) bins and plotted above (AG and CT) or below the line (TC and GA) based on the edited strand. Dots (white/black) indicate recurring SNVs. Genetic organization of SARS-CoV-2 (top). The dark/white shading indicates the viral coding sequences; coverage distribution of all analyzed samples (bottom).</p></caption><graphic xlink:href="abb5813-F2"/></fig><p>The SNV frequency and number of transversions are compatible with the mutation rates observed in coronaviruses [10<sup>&#x02013;6/&#x02212;7</sup>; (<xref rid="R39" ref-type="bibr"><italic>39</italic></xref>)] and commonly associated to the RNA-dependent RNA polymerases (RdRps). RdRps are error prone and are considered the main source of mutations in RNA viruses. However, the coronavirus <italic>nsp14-ExoN</italic> gene provides a form of error correction (<xref rid="R40" ref-type="bibr"><italic>40</italic></xref>), which is probably the reason mutation rates in coronaviruses are lower than those observed in RNA viruses with smaller genomes. The mutational spectrum in SARS quasispecies presents a very weak bias toward U-to-G. Inactivation of nsp14-ExoN error correction reveals the mutational spectrum of the RdRp, which is quite different from the pattern we observe (i.e., main changes are C-to-A, followed by U-to-C, G-to-U, A-to-C, and U-to-G) (<xref rid="R41" ref-type="bibr"><italic>41</italic></xref>). Hence, we would consider that SNVs deriving from RdRp errors represent a marginal fraction of the SNVs in the SARS-CoV-2 samples.</p><p>The bias toward transitions&#x02014;mainly A&#x0003e;G/T&#x0003e;C changes&#x02014;resembles the pattern of SNVs observed in human transcriptomes (<xref rid="R42" ref-type="bibr"><italic>42</italic></xref>) or in viruses (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>, <xref rid="R10" ref-type="bibr"><italic>10</italic></xref>, <xref rid="R18" ref-type="bibr"><italic>18</italic></xref>), where A&#x0003e;G changes derive from deamination of A-to-I mediated by the ADARs. It is thus likely that the A&#x0003e;G/T&#x0003e;C changes seen in SARS-CoV-2 are also due to the action of ADARs.</p><p>C&#x0003e;T and G&#x0003e;A SNVs are the second main group of changes and could derive from APOBEC-mediated C-to-U deamination. Unlike A-to-I editing, C-to-U editing is a relatively rare phenomenon in the human transcriptome (<xref rid="R42" ref-type="bibr"><italic>42</italic></xref>), and with regard to viruses, it has been associated only with positive-sense ssRNA rubella virus (<xref rid="R32" ref-type="bibr"><italic>32</italic></xref>), where C&#x0003e;T changes represent the predominant SNV type. The observation that only A-to-I editing is present in RNA viruses that infect nonvertebrate animals, where RNA-targeting APOBECs are not present (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>, <xref rid="R18" ref-type="bibr"><italic>18</italic></xref>), supports the hypothesis that APOBECs are involved in the RNA editing of this human-targeting virus.</p><p>A third group of SNVs, A&#x0003e;T/T&#x0003e;A transversions, is also present in these samples. While this type of SNV has been reported in other genomic studies (<xref rid="R43" ref-type="bibr"><italic>43</italic></xref>), its origin is still unknown.</p><p>A&#x0003e;G and T&#x0003e;C changes are evenly represented with respect to SNV frequency (<xref rid="F2" ref-type="fig">Fig. 2A</xref>), the number of unique SNVs (<xref rid="F2" ref-type="fig">Fig. 2, B and C</xref>), and their distribution across the viral genome (<xref rid="F2" ref-type="fig">Fig. 2D</xref>). As ADARs target dsRNA, this suggests that dsRNA encompasses the entire genome. While dsRNA in human transcripts is often driven by inverted repeats, the most likely source of dsRNA in the viral transcripts is replication, where both positive and negative strands are present and can result in wide regions of dsRNA.</p><p>Unlike A-to-I changes, C-to-U changes are biased toward the positive-sense strand (<xref rid="F2" ref-type="fig">Fig. 2, B to D</xref>; <italic>P</italic> &#x0003c; 0.0001). Because ADARs and APOBECs selectively target dsRNA and ssRNA, this distribution could arise from the presence at all times of RNA in a dynamic equilibrium between double-strandedness&#x02014;when negative-sense RNA is being transcribed&#x02014;and single-strandedness&#x02014;when nascent RNA is released. Although some areas seem to bear fewer SNVs, these reduced SNV frequencies might be related to lower sequencing depth in those regions.</p><p>As APOBEC deaminases preferentially target cytosines within specific sequence contexts, we analyzed the nucleotide context of A-to-I and C-to-U SNVs in the viral genome (<xref rid="F3" ref-type="fig">Fig. 3, A and B</xref>). A slight depletion of G bases in position &#x02212;1 is present at A-to-I edited positions. This depletion is not as strong as the signal previously reported in human transcripts (<xref rid="R44" ref-type="bibr"><italic>44</italic></xref>&#x02013;<xref rid="R47" ref-type="bibr"><italic>47</italic></xref>). The low editing frequencies we observe resembles the editing present on human transcripts containing Alu sequences, which were found in a limited number in those early datasets. There is no evidence of a sequence context preference if we use a larger dataset such as REDIportal (<xref rid="R48" ref-type="bibr"><italic>48</italic></xref>), which includes &#x0003e;1.5 M sites in Alu repeats (fig. S3).</p><fig id="F3" fig-type="figure" orientation="portrait" position="float"><label>Fig. 3</label><caption><title>Sequence contexts for SARS-CoV-2 RNA edited sites.</title><p>(<bold>A</bold>) Local sequence context for A-to-I and C-to-U edited sites in the viral transcriptome and (<bold>B</bold>) for recurring sites.</p></caption><graphic xlink:href="abb5813-F3"/></fig><p>On the other hand, C-to-U changes preferentially occur downstream from uridines and adenosines, within a sequence context that resembles the one observed for APOBEC1-mediated deamination ([AU]C[AU]) (<xref rid="R49" ref-type="bibr"><italic>49</italic></xref>, <xref rid="R50" ref-type="bibr"><italic>50</italic></xref>).</p><p>We then aligned available genomes from SARS-CoV-2, Middle-East respiratory syndrome&#x02013;related coronavirus (MERS-CoV), and SARS-CoV to test whether RNA editing could be responsible for some of the mutations acquired through evolution. The genomic alignments reveal that a substantial fraction of the mutations in all strains could derive from enzymatic deaminations (<xref rid="F4" ref-type="fig">Fig. 4, A to C</xref>), with a prevalence of C-to-U mutations, and a sequence context compatible with APOBEC-mediated editing also exists in the genomic C-to-U SNVs (<xref rid="F4" ref-type="fig">Fig. 4, D to F</xref>).</p><fig id="F4" fig-type="figure" orientation="portrait" position="float"><label>Fig. 4</label><caption><title>Nucleotide changes across Coronaviridae strains.</title><p>(<bold>A</bold> to <bold>C</bold>) Number of SNVs for each nucleotide change and (<bold>D</bold> to <bold>F</bold>) local sequence context for C-to-U edited sites in genome alignments from SARS-CoV-2 (A and D), human-hosted MERS-CoV (B and E), and human-hosted SARS-CoV (C and F).</p></caption><graphic xlink:href="abb5813-F4"/></fig></sec><sec sec-type="discussion" disp-level="1"><title>DISCUSSION</title><p>Our data source&#x02014;metagenomic sequencing&#x02014;raises the question whether the low-level editing we observe (~1%) reflects the actual levels of editing of viral transcripts within human cells. Aside from a small fraction of cellular transcripts edited at high frequency, most ADAR-edited sites in the human transcriptome (typically inside Alu sequences) present editing levels of ~1% (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>, <xref rid="R42" ref-type="bibr"><italic>42</italic></xref>, <xref rid="R51" ref-type="bibr"><italic>51</italic></xref>). It has been shown that a fraction of the cellular transcripts are hyperedited by ADARs (<xref rid="R52" ref-type="bibr"><italic>52</italic></xref>&#x02013;<xref rid="R54" ref-type="bibr"><italic>54</italic></xref>). While we were unable to observe hyperedited reads in the metagenomic samples, it is possible that hyperedited transcripts fail to be packaged into the virus.</p><p>With regard to APOBEC-mediated RNA editing, its detection in the viral transcriptomes is already indicative, as this type of editing is almost undetectable in human tissues (<xref rid="R42" ref-type="bibr"><italic>42</italic></xref>). This enrichment points either toward an induction of APOBECs triggered by coronavirus infection or to specific targeting of the APOBECs to the viral transcripts. APOBECs have been proved effective against many viral species in experimental conditions, yet, until now, their mutational activity in clinical settings has been shown only in a handful of viral infections (<xref rid="R19" ref-type="bibr"><italic>19</italic></xref>&#x02013;<xref rid="R26" ref-type="bibr"><italic>26</italic></xref>) through DNA editing and, in rubella virus, on RNA (<xref rid="R32" ref-type="bibr"><italic>32</italic></xref>).</p><p>As in rubella virus, we observe a bias in APOBEC editing toward the positive-sense strand. This bias and the low editing frequencies might be indicative of the dynamics of the virus, from transcription to selection of viable genomes. It is reasonable to assume that sites edited on the negative-sense strand will result in a mid-level editing frequency, as not all negative-sense transcripts will be edited (<xref rid="F5" ref-type="fig">Fig. 5A</xref>). On the other hand, editing of the positive-sense strand can occur upon entry of the viral genome, thus yielding high-frequency editing (<xref rid="F5" ref-type="fig">Fig. 5B</xref>), or after viral genome replication, resulting in low-frequency editing (<xref rid="F5" ref-type="fig">Fig. 5C</xref>). The lack of a sizable fraction of highly edited C&#x0003e;T SNVs suggests that APOBEC editing occurs late in the viral life cycle (<xref rid="F5" ref-type="fig">Fig. 5C</xref>). Yet, because they occur earlier, G&#x0003e;A SNVs should be closer in number to C&#x0003e;T SNVs and with higher levels of editing, which is not what we observe (<xref rid="F2" ref-type="fig">Fig. 2, A to C</xref>). The overrepresentation of C&#x0003e;T SNVs could be due to an imbalance toward positive-sense transcripts, as these are continuously generated from the negative-sense ones (and double-stranded hybrid RNAs are lost). However, the editing frequencies of G&#x0003e;A SNVs should be much higher, as G&#x0003e;A SNVs are generated upstream to the C&#x0003e;T ones. A more fitting explanation is that editing of the negative-sense transcripts results in loss of the edited transcript (<xref rid="F5" ref-type="fig">Fig. 5D</xref>), possibly because editing triggers nonsense-mediated decay (<xref rid="R55" ref-type="bibr"><italic>55</italic></xref>), thus lowering the chances of the edited site to be transmitted.</p><fig id="F5" fig-type="figure" orientation="portrait" position="float"><label>Fig. 5</label><caption><title>Model of APOBEC RNA editing on SARS-CoV-2 transcriptome.</title><p>The four panels model the editing frequencies and the C&#x0003e;U/G/A ratios expected from four different scenarios: (<bold>A</bold>) C-to-U editing on the negative-sense transcripts, (<bold>B</bold>) &#x0201c;early&#x0201d; editing on the viral genomes before viral replication, (<bold>C</bold>) &#x0201c;late&#x0201d; editing after viral replication, and (<bold>D</bold>) &#x0201c;late&#x0201d; editing after viral replication with loss of negative-sense transcripts. Red dots indicate editing on the positive-sense transcript; orange dots indicate editing on the positive-sense transcript. Green and blue segments indicate positive- and negative-sense viral transcripts, respectively.</p></caption><graphic xlink:href="abb5813-F5"/></fig><p>Because most of the APOBECs are unable to target RNA, the only well-characterized cytidine-targeting deaminases are APOBEC1, mainly expressed in the gastrointestinal tract, and APOBEC3A (<xref rid="R56" ref-type="bibr"><italic>56</italic></xref>), whose physiological role is not clear. As with A-to-I editing, it will be important to assess the true extent of APOBEC RNA editing in infected cells.</p><p>The functional meaning of RNA editing in SARS-CoV-2 is yet to be understood: In other contexts, editing of the viral genome determines its demise or fuels its evolution. For DNA viruses, the selection is indirect, as genomes evolve to reduce potentially harmful editable sites [e.g., (<xref rid="R18" ref-type="bibr"><italic>18</italic></xref>)], but for RNA viruses, this pressure is even stronger, as RNA editing directly affects the genetic information and efficiently edited sites disappear.</p><p>A comparison of the SNV datasets from the transcriptomic and genomic analyses reveals a different weight of A-to-I and C-to-U changes (<xref rid="F2" ref-type="fig">Figs. 2B</xref> and <xref rid="F4" ref-type="fig">4A</xref>), with an underrepresentation of A-to-I in the viral genomes. As our analysis underestimates the amount of editing due to the strict parameters used, the underrepresentation of A-to-I changes could be explained by the possibility that A-to-I editing is more effective in restricting viral propagation, thus reducing the number of viral progeny showing evidence of these changes. In contrast, the remnants of less effective C-to-U editing are retained in viral progeny and get fixed during viral adaptation.</p><p>An analysis of mutation outcomes is difficult due to the low numbers of events collected so far, but there are some possibly suggestive trends (data S2). C-to-U changes leading to stop codons are overrepresented in the transcriptomic data but&#x02014;as expected&#x02014;disappear in the genomic dataset. This might point&#x02014;again&#x02014;to an antiviral role for these editing enzymes. There is also an underrepresentation of C&#x0003e;T missense mutations, but its meaning is difficult to interpret.</p><p>Last, this analysis is a first step in understanding the involvement of RNA editing in viral replication, and it could lead to clinically relevant outcomes: (i) If these enzymes are relevant in the host response to coronavirus infection, a deletion polymorphism quite common in the Chinese population, encompassing the end of <italic>APOBEC3A</italic> and most of <italic>APOBEC3B</italic> (<xref rid="R57" ref-type="bibr"><italic>57</italic></xref>, <xref rid="R58" ref-type="bibr"><italic>58</italic></xref>), could play a role in the spread of the infection. (ii) Because RNA editing and selection act orthogonally in the evolution of the viruses, comparing genomic sites that are edited with those that are mutated could lead to the selection of viral regions potentially exploitable for therapeutic uses.</p></sec><sec sec-type="materials|methods" disp-level="1"><title>MATERIALS AND METHODS</title><sec disp-level="2"><title>Sequencing data</title><p>RNA sequencing data available from projects PRJNA601736, PRJNA603194, and PRJNA605907 were downloaded from the National Center for Biotechnology Information (NCBI; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/">https://www.ncbi.nlm.nih.gov/sra/</ext-link>) using the FASTQ-dump utilities from the SRA-toolkit with the following command line:</p><p><monospace>prefetch -v SRR* &#x00026;&#x00026; fastq-dump --outdir /path_dir/ | --split-files /path_dir/SRR*.sra</monospace></p><p>Because most of the reads of samples from PRJNA605907 were missing their mate, forward-reads and reverse-reads from these samples have been merged in a single FASTQ, which is treated as a single-end experiment. Details of the sequencing runs are summarized in data S1.</p></sec><sec disp-level="2"><title>Data preprocessing</title><p>SRR11059940, SRR11059941, SRR11059942, and SRR11059945 showed a reduced quality of the sequencing in the terminal part of the reads. We used TRIMMOMATIC (<xref rid="R59" ref-type="bibr"><italic>59</italic></xref>) to trim the reads of those samples to 100 base pairs (bp), with the following command line:</p><p><monospace>rimmomatic SE SRR*.fastq SRR*.trimmed.fastq CROP:100</monospace></p><p>We aligned the FASTQ files using Burrows-Wheeler Aligner (<xref rid="R60" ref-type="bibr"><italic>60</italic></xref>) using the official sequence of SARS-CoV-2 (NC_045512. 2) as reference genome. After the alignments, BAM files were sorted using SAMtools (<xref rid="R61" ref-type="bibr"><italic>61</italic></xref>).</p><p>The command line used for paired-end samples is as follows:</p><p><monospace>bwa mem NC_045512.2.fa SRR*_1.fastq SRR*_2.fastq | samtools sort &#x02013;O BAM -o SRR*_.bam</monospace></p><p>The command line used for single-end samples is as follows:</p><p><monospace>bwa mem NC_045512.2.fa SRR*.fastq | samtools sort &#x02013;O BAM -o SRR*_.bam</monospace></p><p>The aligned bams have been analyzed with QUALIMAP (<xref rid="R62" ref-type="bibr"><italic>62</italic></xref>). Because of a high error rate reported by QUALIMAP, samples SRR11059943 and SRR10971381 have been removed from the analysis.</p></sec><sec disp-level="2"><title>SNV calling</title><p>A diagram of the entire pipeline is shown in fig. S1A. We used REDItools 2 (<xref rid="R35" ref-type="bibr"><italic>35</italic></xref>, <xref rid="R37" ref-type="bibr"><italic>37</italic></xref>) and JACUSA (<xref rid="R38" ref-type="bibr"><italic>38</italic></xref>) to call the SNVs using the following command line:</p><p><monospace>python2.7 reditools.py -f SRR*.bam -o SRR10903401_stat_table_allPos.txt -S -s 0 -os 4 -m /homol_site/SRR*_homopol.txt -c SRR*_homopol.txt -r /Reference/NC_045512.2.fa -a SRR*_stat_table_allPos.txt -q 25 -bq 35 -mbp 15 -Mbp 15</monospace></p><p><monospace>jacusa call-1 -p 20 -r SRR*.vcf -a B,I,Y -s -f V -q 35 -m 25 SRR*.srt.bam</monospace></p><p>With regard to REDItools 2, we removed all SNVs within 15 nucleotides from the beginning or the end of the reads to avoid artifacts due to misalignments.</p><p>To avoid potential artifacts due to strand bias, we used the AS_StrandOddsRatio parameter, calculated following GATK guidelines (<ext-link ext-link-type="uri" xlink:href="https://gatk.broadinstitute.org/hc/en-us/articles/360040507111-AS-StrandOddsRatio">https://gatk.broadinstitute.org/hc/en-us/articles/360040507111-AS-StrandOddsRatio</ext-link>), and any mutation with an AS_StrandOddsRatio &#x0003e; 4 has been removed from the dataset.</p><p>Bcftools (<xref rid="R61" ref-type="bibr"><italic>61</italic></xref>) has been used to calculate total allelic depths on the forward and reverse strand (ADF and ADR) for AS_StrandOddsRatio calculation, with the following command line:</p><p><monospace>mpileup -a FORMAT/AD,FORMAT/ADF,FORMAT/ADR,FORMAT/DP,FORMAT/SP -O v -A -C -I -d 1000000 -q 25 -Q 35 -f NC_045512.2.fa -o SRR*.vcf SRR*.srt.bam</monospace></p><p>Mutations common to the datasets generated by REDItools 2 and JACUSA were considered (<italic>n</italic> = 910; fig. S2 and data S3). The threshold we used to filter the SNVs is based on minimum coverage (20 reads), number of supporting reads (at least four mutated reads), allelic fraction (0.5%), quality of the mapped reads (&#x0003e;25), and base quality (&#x0003e;35). In the dataset, there were only six SNVs with allelic fractions in the range of 30 to 85% (C&#x0003e;T, 1; T&#x0003e;C, 3; G&#x0003e;T, 2). Because there were no SNVs with higher allelic fractions, we presume that all samples originated from the same viral strain.</p><p>Recurring SNVs have been defined as the SNVs present in at least two samples. To overcome the problem of samples with lower sequencing depth, we used the positions of the SNVs common to both REDItools 2 and JACUSA to call again the SNVs irrespectively of the number of supporting reads.</p></sec><sec disp-level="2"><title>Data manipulation</title><p>R packages (Biostrings, rsamtools, ggseqlogo ggplot2, and splitstackshape) and custom Perl scripts were used to handle the data.</p></sec><sec disp-level="2"><title>Sequence context analysis</title><p>Logo alignments were calculated using ggseqlogo, using either the pooled dataset or the dataset of recurring SNVs. Logo alignments of the human edited sites were performed using ADAR sites from REDIportal (<xref rid="R48" ref-type="bibr"><italic>48</italic></xref>) that were shared by at least four samples. SARS-CoV-2, SARS, and MERS genomic data were prepared for the Logi alignment using the GenomicRanges R package (<xref rid="R63" ref-type="bibr"><italic>63</italic></xref>).</p></sec><sec disp-level="2"><title>SNV calling in genomic data from SARS-CoV-2, SARS, and MERS</title><p>The viral genomic sequences of MERS (taxid:1335626) and SARS (taxid:694009) were selected on NCBI Virus (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/">https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/</ext-link>) using the following query: Host : Homo Sapiens (human), taxid:9606; -Nucleotide Sequence Type: Complete. They were aligned using the &#x0201c;Align&#x0201d; utility. Consensus sequences of SARS and MERS genomes were built using the &#x0201c;cons&#x0201d; tool from the EMBOSS suite (<ext-link ext-link-type="uri" xlink:href="http://bioinfo.nhri.org.tw/gui/">http://bioinfo.nhri.org.tw/gui/</ext-link>) with default settings. SARS-CoV-2 genomic sequences were downloaded from GISAID (<ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org/">https://www.gisaid.org/</ext-link>) and aligned with MUSCLE (<xref rid="R64" ref-type="bibr"><italic>64</italic></xref>).</p><p>SNVs have been called with a custom R script, by comparing viral genome sequences to the respective consensus sequence or, for SARS-CoV-2, to the NC_045512.2 reference sequence. SNVs, viral consensus sequences, and Coronaviridae genome sequence identifiers are provided in data S3 to S5.</p></sec><sec disp-level="2"><title>SNV annotation</title><p>SNVs (from both genomic and somatic SNV sets) occurring on coding sequences have been annotated with custom R scripts to determine the outcome of the nucleotide change (nonsense/missense/synonymous mutation). A summary is reported in data S2.</p></sec><sec disp-level="2"><title>Statistical analysis</title><p>fisher.test() function from the R base package has been used for all the statistical tests. To test the significance of C-to-U bias on the positive strand, we compared C&#x0003e;T/G&#x0003e;A SNV counts to the count of C/G bases on the reference genome. For <italic>P</italic> values of &#x0201c;RNA vs Reference,&#x0201d; &#x0201c;DNA vs Reference,&#x0201d; and &#x0201c;genome vs RNA,&#x0201d; 2 &#x000d7; 2 contingency tables have been generated as shown in data S2.</p></sec></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>abb5813_DataS6.csv</title>
</caption>
<media mimetype="text" mime-subtype="plain" xlink:href="abb5813_DataS6.csv"/>
</supplementary-material>
<supplementary-material id="PMC_2" content-type="local-data">
<caption>
<title>abb5813_DataS2.xlsx</title>
</caption>
<media mimetype="application" mime-subtype="vnd.ms-excel"
xlink:href="abb5813_DataS2.xlsx"/>
</supplementary-material>
<supplementary-material id="PMC_3" content-type="local-data">
<caption>
<title>abb5813_DataS3.xlsx</title>
</caption>
<media mimetype="application" mime-subtype="vnd.ms-excel"
xlink:href="abb5813_DataS3.xlsx"/>
</supplementary-material>
<supplementary-material id="PMC_4" content-type="local-data">
<caption>
<title>abb5813_DataS5.txt</title>
</caption>
<media mimetype="text" mime-subtype="plain" xlink:href="abb5813_DataS5.txt"/>
</supplementary-material>
<supplementary-material id="PMC_5" content-type="local-data">
<caption>
<title>abb5813_DataS4.txt</title>
</caption>
<media mimetype="text" mime-subtype="plain" xlink:href="abb5813_DataS4.txt"/>
</supplementary-material>
<supplementary-material id="PMC_6" content-type="local-data">
<caption>
<title>abb5813_SM.pdf</title>
</caption>
<media mimetype="application" mime-subtype="pdf" xlink:href="abb5813_SM.pdf"/>
</supplementary-material>
<supplementary-material id="PMC_7" content-type="local-data">
<caption>
<title>abb5813_DataS1.txt</title>
</caption>
<media mimetype="text" mime-subtype="plain" xlink:href="abb5813_DataS1.txt"/>
</supplementary-material>
<supplementary-material id="PMC_8" content-type="local-data">
<caption>
<title>abb5813_DataS7.txt</title>
</caption>
<media mimetype="text" mime-subtype="plain" xlink:href="abb5813_DataS7.txt"/>
</supplementary-material>
</sec>
</body><back><ack><title>Acknowledgments</title><p>In memory of Li Wenliang, Carlo Urbani, and all the doctors and health workers who endangered their lives in the fight against epidemics. We acknowledge and thank all authors that are sharing their data. We gratefully acknowledge the authors, originating and submitting laboratories, of the sequences from GISAID&#x02019;s EpiFlu Database on which this research is based. The list is detailed in data S6. We thank Ernesto Picardi for the support with REDItools2. <bold>Funding:</bold> The research was supported by grants from Ministero della Salute (PE-2013-02357669) and from AIRC (IG-17701). <bold>Author contributions:</bold> Conceptualization: S.D.G., F.M., M.G.T., G.M., and S.G.C.; formal analysis, investigation, and software: S.D.G. and F.M.; visualization: G.M.; writing (original draft): G.M. and S.G.C.; writing (review and editing): S.D.G., F.M., M.G.T., G.M., and S.G.C. <bold>Competing interests:</bold> The authors declare that they have no competing interests. <bold>Data and materials availability:</bold> Sequencing and genomic data are available through NCBI SRA and Virus repositories and GISAID. The SNVs dataset is also available through the UCSC genome browser at <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/s/Max/conticello2020">http://genome.ucsc.edu/s/Max/conticello2020</ext-link>.</p></ack><app-group><app><title>SUPPLEMENTARY MATERIALS</title><supplementary-material content-type="local-data"><p>Supplementary material for this article is available at <ext-link ext-link-type="uri" xlink:href="http://advances.sciencemag.org/cgi/content/full/6/25/eabb5813/DC1">http://advances.sciencemag.org/cgi/content/full/6/25/eabb5813/DC1</ext-link></p></supplementary-material></app></app-group><ref-list><title>REFERENCES AND NOTES</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.-M.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>Z.-G.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>Z.-W.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>J.-H.</given-names></name>, <name name-style="western"><surname>Pei</surname><given-names>Y.-Y.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>M.-L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.-L.</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>F.-H.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q.-M.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>J.-J.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>E. C.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.-Z.</given-names></name></person-group>, 
<article-title>A new coronavirus associated with human respiratory disease in China</article-title>. <source>Nature</source>
<volume>579</volume>, 
<fpage>265</fpage>&#x02013;<lpage>269</lpage> (<year>2020</year>). <?supplied-pmid 32015508?><pub-id pub-id-type="pmid">32015508</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>K. S. M.</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>E. H. Y.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>J. Y.</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>T. T. Y.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>G. F.</given-names></name>, <name name-style="western"><surname>Cowling</surname><given-names>B. J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>G. M.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Z.</given-names></name></person-group>, 
<article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia</article-title>. <source>N. Engl. J. Med.</source>
<volume>382</volume>, 
<fpage>1199</fpage>&#x02013;<lpage>1207</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">31995857</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#x02019;Connell</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Mannion</surname><given-names>N. M.</given-names></name>, <name name-style="western"><surname>Keegan</surname><given-names>L. P.</given-names></name></person-group>, 
<article-title>The epitranscriptome and innate immunity</article-title>. <source>PLOS Genet.</source>
<volume>11</volume>, 
<fpage>e1005687</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26658668</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenberg</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Levanon</surname><given-names>E. Y.</given-names></name></person-group>, 
<article-title>A-to-I RNA editing&#x02014;Immune protector and transcriptome diversifier</article-title>. <source>Nat. Rev. Genet.</source>
<volume>19</volume>, 
<fpage>473</fpage>&#x02013;<lpage>490</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29692414</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Dudley</surname><given-names>J. P.</given-names></name></person-group>, 
<article-title>APOBECs and virus restriction</article-title>. <source>Virology</source>
<volume>479&#x02013;480</volume>, 
<fpage>131</fpage>&#x02013;<lpage>145</lpage> (<year>2015</year>).</mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salter</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>H. C.</given-names></name></person-group>, 
<article-title>Modeling the embrace of a mutator: APOBEC selection of nucleic acid ligands</article-title>. <source>Trends Biochem. Sci.</source>
<volume>43</volume>, 
<fpage>606</fpage>&#x02013;<lpage>622</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29803538</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>D. R.</given-names></name>, <name name-style="western"><surname>Puig</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Darnell</surname><given-names>M. E. R.</given-names></name>, <name name-style="western"><surname>Mihalik</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Feinstone</surname><given-names>S. M.</given-names></name></person-group>, 
<article-title>New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1</article-title>. <source>J. Virol.</source>
<volume>79</volume>, 
<fpage>6291</fpage>&#x02013;<lpage>6298</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15858013</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zahn</surname><given-names>R. C.</given-names></name>, <name name-style="western"><surname>Schelp</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Uterm&#x000f6;hlen</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>von Laer</surname><given-names>D.</given-names></name></person-group>, 
<article-title>A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus</article-title>. <source>J. Virol.</source>
<volume>81</volume>, 
<fpage>457</fpage>&#x02013;<lpage>464</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17020943</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phuphuakrat</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kraiwong</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Boonarkart</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lauhakirti</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>T.-H.</given-names></name>, <name name-style="western"><surname>Auewarakul</surname><given-names>P.</given-names></name></person-group>, 
<article-title>Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins</article-title>. <source>J. Virol.</source>
<volume>82</volume>, 
<fpage>10864</fpage>&#x02013;<lpage>10872</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18753201</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carpenter</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Keegan</surname><given-names>L. P.</given-names></name>, <name name-style="western"><surname>Wilfert</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>O&#x02019;Connell</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Jiggins</surname><given-names>F. M.</given-names></name></person-group>, 
<article-title>Evidence for ADAR-induced hypermutation of the Drosophila sigma virus (Rhabdoviridae)</article-title>. <source>BMC Genet.</source>
<volume>10</volume>, 
<fpage>75</fpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19941656</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doria</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Neri</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gallo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Farace</surname><given-names>M. G.</given-names></name>, <name name-style="western"><surname>Michienzi</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection</article-title>. <source>Nucleic Acids Res.</source>
<volume>37</volume>, 
<fpage>5848</fpage>&#x02013;<lpage>5858</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19651874</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>George</surname><given-names>C. X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Okonski</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Toth</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Samuel</surname><given-names>C. E.</given-names></name></person-group>, 
<article-title>Tipping the balance: Antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products</article-title>. <source>J. Interferon Cytokine Res.</source>
<volume>29</volume>, 
<fpage>477</fpage>&#x02013;<lpage>487</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19715457</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clerzius</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>G&#x000e9;linas</surname><given-names>J.-F.</given-names></name>, <name name-style="western"><surname>Gatignol</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Multiple levels of PKR inhibition during HIV-1 replication</article-title>. <source>Rev. Med. Virol.</source>
<volume>21</volume>, 
<fpage>42</fpage>&#x02013;<lpage>53</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21294215</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doria</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tomaselli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Neri</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Ciafr&#x000e8;</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Farace</surname><given-names>M. G.</given-names></name>, <name name-style="western"><surname>Michienzi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gallo</surname><given-names>A.</given-names></name></person-group>, 
<article-title>ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor</article-title>. <source>J. Gen. Virol.</source>
<volume>92</volume>, 
<fpage>1228</fpage>&#x02013;<lpage>1232</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21289159</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfaller</surname><given-names>C. K.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>George</surname><given-names>C. X.</given-names></name>, <name name-style="western"><surname>Samuel</surname><given-names>C. E.</given-names></name></person-group>, 
<article-title>Protein kinase PKR and RNA adenosine deaminase ADAR1: New roles for old players as modulators of the interferon response</article-title>. <source>Curr. Opin. Immunol.</source>
<volume>23</volume>, 
<fpage>573</fpage>&#x02013;<lpage>582</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21924887</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samuel</surname><given-names>C. E.</given-names></name></person-group>, 
<article-title>ADARs: Viruses and innate immunity</article-title>. <source>Curr. Top. Microbiol. Immunol.</source>
<volume>353</volume>, 
<fpage>163</fpage>&#x02013;<lpage>195</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">21809195</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomaselli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Galeano</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Locatelli</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gallo</surname><given-names>A.</given-names></name></person-group>, 
<article-title>ADARs and the balance game between virus infection and innate immune cell response</article-title>. <source>Curr. Issues Mol. Biol.</source>
<volume>17</volume>, 
<fpage>37</fpage>&#x02013;<lpage>51</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25502818</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosani</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>C.-M.</given-names></name>, <name name-style="western"><surname>Maso</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Abbadi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Domeneghetti</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C.-M.</given-names></name>, <name name-style="western"><surname>Cendron</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>MacCarthy</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Venier</surname><given-names>P.</given-names></name></person-group>, 
<article-title>A-to-I editing of <italic>Malacoherpesviridae</italic> RNAs supports the antiviral role of ADAR1 in mollusks</article-title>. <source>BMC Evol. Biol.</source>
<volume>19</volume>, 
<fpage>149</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31337330</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vartanian</surname><given-names>J. P.</given-names></name>, <name name-style="western"><surname>Meyerhans</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Asj&#x000f6;</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wain-Hobson</surname><given-names>S.</given-names></name></person-group>, 
<article-title>Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes</article-title>. <source>J. Virol.</source>
<volume>65</volume>, 
<fpage>1779</fpage>&#x02013;<lpage>1788</lpage> (<year>1991</year>).<pub-id pub-id-type="pmid">2002543</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Bishop</surname><given-names>K. N.</given-names></name>, <name name-style="western"><surname>Sheehy</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>H. M.</given-names></name>, <name name-style="western"><surname>Petersen-Mahrt</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Watt</surname><given-names>I. N.</given-names></name>, <name name-style="western"><surname>Neuberger</surname><given-names>M. S.</given-names></name>, <name name-style="western"><surname>Malim</surname><given-names>M. H.</given-names></name></person-group>, 
<article-title>DNA deamination mediates innate immunity to retroviral infection</article-title>. <source>Cell</source>
<volume>113</volume>, 
<fpage>803</fpage>&#x02013;<lpage>809</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12809610</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahieux</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Susp&#x000e8;ne</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Delebecque</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Wain-Hobson</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vartanian</surname><given-names>J.-P.</given-names></name></person-group>, 
<article-title>Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases</article-title>. <source>J. Gen. Virol.</source>
<volume>86</volume>, 
<fpage>2489</fpage>&#x02013;<lpage>2494</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16099907</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noguchi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ishino</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tsuge</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fujimoto</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Imamura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chayama</surname><given-names>K.</given-names></name></person-group>, 
<article-title>G to A hypermutation of hepatitis B virus</article-title>. <source>Hepatology</source>
<volume>41</volume>, 
<fpage>626</fpage>&#x02013;<lpage>633</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15726649</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vartanian</surname><given-names>J.-P.</given-names></name>, <name name-style="western"><surname>Gu&#x000e9;tard</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wain-Hobson</surname><given-names>S.</given-names></name></person-group>, 
<article-title>Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions</article-title>. <source>Science</source>
<volume>320</volume>, 
<fpage>230</fpage>&#x02013;<lpage>233</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18403710</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Susp&#x000e8;ne</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Aynaud</surname><given-names>M.-M.</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pasdeloup</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Labetoulle</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gaertner</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Vartanian</surname><given-names>J.-P.</given-names></name>, <name name-style="western"><surname>Meyerhans</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wain-Hobson</surname><given-names>S.</given-names></name></person-group>, 
<article-title>Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and <italic>in vivo</italic></article-title>. <source>J. Virol.</source>
<volume>85</volume>, 
<fpage>7594</fpage>&#x02013;<lpage>7602</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21632763</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuevas</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Geller</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Garijo</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>L&#x000f3;pez-Aldeguer</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sanju&#x000e1;n</surname><given-names>R.</given-names></name></person-group>, 
<article-title>Extremely high mutation rate of HIV-1 in vivo</article-title>. <source>PLOS Biol.</source>
<volume>13</volume>, 
<fpage>e1002251</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26375597</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peretti</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Geoghegan</surname><given-names>E. M.</given-names></name>, <name name-style="western"><surname>Pastrana</surname><given-names>D. V.</given-names></name>, <name name-style="western"><surname>Smola</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Feld</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Sauter</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lohse</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ramesh</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>E. S.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Borgogna</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>FitzGerald</surname><given-names>P. C.</given-names></name>, <name name-style="western"><surname>Bliskovsky</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Starrett</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Law</surname><given-names>E. K.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Killian</surname><given-names>J. K.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pineda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Meltzer</surname><given-names>P. S.</given-names></name>, <name name-style="western"><surname>Boldorini</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gariglio</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Buck</surname><given-names>C. B.</given-names></name></person-group>, 
<article-title>Characterization of BK polyomaviruses from kidney transplant recipients suggests a role for APOBEC3 in driving in-host virus evolution</article-title>. <source>Cell Host Microbe</source>
<volume>23</volume>, 
<fpage>628</fpage>&#x02013;<lpage>635.e7</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29746834</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newman</surname><given-names>E. N. C.</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>R. K.</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>H. M.</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>K. C.</given-names></name>, <name name-style="western"><surname>Lingappa</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Malim</surname><given-names>M. H.</given-names></name>, <name name-style="western"><surname>Sheehy</surname><given-names>A. M.</given-names></name></person-group>, 
<article-title>Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity</article-title>. <source>Curr. Biol.</source>
<volume>15</volume>, 
<fpage>166</fpage>&#x02013;<lpage>170</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15668174</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pollpeter</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Parsons</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sobala</surname><given-names>A. E.</given-names></name>, <name name-style="western"><surname>Coxhead</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Bruns</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Papaioannou</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>McDonnell</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Apolonia</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Chowdhury</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Horvath</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Malim</surname><given-names>M. H.</given-names></name></person-group>, 
<article-title>Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G</article-title>. <source>Nat. Microbiol.</source>
<volume>3</volume>, 
<fpage>220</fpage>&#x02013;<lpage>233</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29158605</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milewska</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kindler</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Vkovski</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zeglen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ochman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Thiel</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Rajfur</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Pyrc</surname><given-names>K.</given-names></name></person-group>, 
<article-title>APOBEC3-mediated restriction of RNA virus replication</article-title>. <source>Sci. Rep.</source>
<volume>8</volume>, 
<fpage>5960</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29654310</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albin</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Hach&#x000e9;</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Hultquist</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>W. L.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>R. S.</given-names></name></person-group>, 
<article-title>Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function</article-title>. <source>J. Virol.</source>
<volume>84</volume>, 
<fpage>10209</fpage>&#x02013;<lpage>10219</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20686027</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadler</surname><given-names>H. A.</given-names></name>, <name name-style="western"><surname>Stenglein</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Mansky</surname><given-names>L. M.</given-names></name></person-group>, 
<article-title>APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis</article-title>. <source>J. Virol.</source>
<volume>84</volume>, 
<fpage>7396</fpage>&#x02013;<lpage>7404</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20463080</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perelygina</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>M.-H.</given-names></name>, <name name-style="western"><surname>Suppiah</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Adebayo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Abernathy</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Dorsey</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bercovitch</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Paris</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>White</surname><given-names>K. P.</given-names></name>, <name name-style="western"><surname>Krol</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dhossche</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Torshin</surname><given-names>I. Y.</given-names></name>, <name name-style="western"><surname>Saini</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Klimczak</surname><given-names>L. J.</given-names></name>, <name name-style="western"><surname>Gordenin</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Zharkikh</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Plotkin</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sullivan</surname><given-names>K. E.</given-names></name>, <name name-style="western"><surname>Icenogle</surname><given-names>J.</given-names></name></person-group>, 
<article-title>Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies</article-title>. <source>PLOS Pathog.</source>
<volume>15</volume>, 
<fpage>e1008080</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31658304</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Mei</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lan</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name></person-group>, 
<article-title>RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak</article-title>. <source>Emerg. Microbes Infect.</source>
<volume>9</volume>, 
<fpage>313</fpage>&#x02013;<lpage>319</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32020836</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name></person-group>, 
<article-title>Genomic diversity of SARS-CoV-2 in coronavirus disease 2019 patients</article-title>. <source>Clin. Infect. Dis.</source> , 
<fpage>ciaa203</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32129843</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Picardi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pesole</surname><given-names>G.</given-names></name></person-group>, 
<article-title>REDItools: High-throughput RNA editing detection made easy</article-title>. <source>Bioinformatics</source>
<volume>29</volume>, 
<fpage>1813</fpage>&#x02013;<lpage>1814</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23742983</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo Giudice</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Tangaro</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Pesole</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Picardi</surname><given-names>E.</given-names></name></person-group>, 
<article-title>Investigating RNA editing in deep transcriptome datasets with REDItools and REDIportal</article-title>. <source>Nat. Protoc.</source>
<volume>15</volume>, 
<fpage>1098</fpage>&#x02013;<lpage>1131</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">31996844</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="other">T. Flati, S. Gioiosa, N. Spallanzani, I. Tagliaferri, M. Angela Diroma, G. Pesole, G. Chillemi, E. Picardi, T. Castrignan&#x000f2;, HPC-REDItools: A novel HPC-aware tool for improved large scale RNA-editing analysis. bioRxiv 2020.04.30.069732 [<bold>Preprint</bold>]. 30 April 2020. <pub-id pub-id-type="doi">10.1101/2020.04.30.069732</pub-id>.</mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piechotta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wyler</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ohler</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Landthaler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dieterich</surname><given-names>C.</given-names></name></person-group>, 
<article-title>JACUSA: Site-specific identification of RNA editing events from replicate sequencing data</article-title>. <source>BMC Bioinformatics</source>
<volume>18</volume>, 
<fpage>7</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28049429</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eckerle</surname><given-names>L. D.</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Halpin</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Venter</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Scherbakova</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>R. L.</given-names></name>, <name name-style="western"><surname>Baric</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Stockwell</surname><given-names>T. B.</given-names></name>, <name name-style="western"><surname>Spiro</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Denison</surname><given-names>M. R.</given-names></name></person-group>, 
<article-title>Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing</article-title>. <source>PLOS Pathog.</source>
<volume>6</volume>, 
<fpage>e1000896</fpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20463816</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denison</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>R. L.</given-names></name>, <name name-style="western"><surname>Donaldson</surname><given-names>E. F.</given-names></name>, <name name-style="western"><surname>Eckerle</surname><given-names>L. D.</given-names></name>, <name name-style="western"><surname>Baric</surname><given-names>R. S.</given-names></name></person-group>, 
<article-title>Coronaviruses</article-title>. <source>RNA Biol.</source>
<volume>8</volume>, 
<fpage>270</fpage>&#x02013;<lpage>279</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21593585</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>E. C.</given-names></name>, <name name-style="western"><surname>Blanc</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Surdel</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Vignuzzi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Denison</surname><given-names>M. R.</given-names></name></person-group>, 
<article-title>Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: Evidence for proofreading and potential therapeutics</article-title>. <source>PLOS Pathog.</source>
<volume>9</volume>, 
<fpage>e1003565</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23966862</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bazak</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Haviv</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Barak</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jacob-Hirsch</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Isaacs</surname><given-names>F. J.</given-names></name>, <name name-style="western"><surname>Rechavi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J. B.</given-names></name>, <name name-style="western"><surname>Eisenberg</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Levanon</surname><given-names>E. Y.</given-names></name></person-group>, 
<article-title>A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes</article-title>. <source>Genome Res.</source>
<volume>24</volume>, 
<fpage>365</fpage>&#x02013;<lpage>376</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24347612</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bar-Yaacov</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Avital</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Richards</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Hachen</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Rebolledo Jaramillo</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Nekrutenko</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zarivach</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Mishmar</surname><given-names>D.</given-names></name></person-group>, 
<article-title>RNA&#x02013;DNA differences in human mitochondria restore ancestral form of 16S ribosomal RNA</article-title>. <source>Genome Res.</source>
<volume>23</volume>, 
<fpage>1789</fpage>&#x02013;<lpage>1796</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23913925</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lehmann</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Bass</surname><given-names>B. L.</given-names></name></person-group>, 
<article-title>Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities</article-title>. <source>Biochemistry</source>
<volume>39</volume>, 
<fpage>12875</fpage>&#x02013;<lpage>12884</lpage> (<year>2000</year>).<pub-id pub-id-type="pmid">11041852</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J. B.</given-names></name>, <name name-style="western"><surname>Levanon</surname><given-names>E. Y.</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>J.-K.</given-names></name>, <name name-style="western"><surname>Aach</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Leproust</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Church</surname><given-names>G. M.</given-names></name></person-group>, 
<article-title>Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing</article-title>. <source>Science</source>
<volume>324</volume>, 
<fpage>1210</fpage>&#x02013;<lpage>1213</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19478186</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bahn</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.-H.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Greer</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>X.</given-names></name></person-group>, 
<article-title>Accurate identification of A-to-I RNA editing in human by transcriptome sequencing</article-title>. <source>Genome Res.</source>
<volume>22</volume>, 
<fpage>142</fpage>&#x02013;<lpage>150</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">21960545</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Picardi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Manzari</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mastropasqua</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Aiello</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>D&#x02019;Erchia</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Pesole</surname><given-names>G.</given-names></name></person-group>, 
<article-title>Profiling RNA editing in human tissues: Towards the inosinome Atlas</article-title>. <source>Sci. Rep.</source>
<volume>5</volume>, 
<fpage>14941</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26449202</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Picardi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>D&#x02019;Erchia</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Lo Giudice</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pesole</surname><given-names>G.</given-names></name></person-group>, 
<article-title>REDIportal: A comprehensive database of A-to-I RNA editing events in humans</article-title>. <source>Nucleic Acids Res.</source>
<volume>45</volume>, 
<fpage>D750</fpage>&#x02013;<lpage>D757</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">27587585</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>B. R.</given-names></name>, <name name-style="western"><surname>Hamilton</surname><given-names>C. E.</given-names></name>, <name name-style="western"><surname>Mwangi</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Dewell</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Papavasiliou</surname><given-names>F. N.</given-names></name></person-group>, 
<article-title>Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3&#x02019; UTRs</article-title>. <source>Nat. Struct. Mol. Biol.</source>
<volume>18</volume>, 
<fpage>230</fpage>&#x02013;<lpage>236</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21258325</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lerner</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Papavasiliou</surname><given-names>F. N.</given-names></name>, <name name-style="western"><surname>Pecori</surname><given-names>R.</given-names></name></person-group>, 
<article-title>RNA editors, cofactors, and mRNA targets: An overview of the C-to-U RNA editing machinery and its implication in human disease</article-title>. <source>Genes</source>
<volume>10</volume>, 
<fpage>13</fpage> (<year>2018</year>).</mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>S. H.</given-names></name>, <name name-style="western"><surname>Levanon</surname><given-names>E. Y.</given-names></name>, <name name-style="western"><surname>Eisenberg</surname><given-names>E.</given-names></name></person-group>, 
<article-title>Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity</article-title>. <source>Nat. Methods</source>
<volume>16</volume>, 
<fpage>1131</fpage>&#x02013;<lpage>1138</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31636457</pub-id></mixed-citation></ref><ref id="R52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osenberg</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Dominissini</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Rechavi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Eisenberg</surname><given-names>E.</given-names></name></person-group>, 
<article-title>Widespread cleavage of A-to-I hyperediting substrates</article-title>. <source>RNA</source>
<volume>15</volume>, 
<fpage>1632</fpage>&#x02013;<lpage>1639</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19622679</pub-id></mixed-citation></ref><ref id="R53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>N. L.</given-names></name>, <name name-style="western"><surname>Birlouez</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wain-Hobson</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mahieux</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Vartanian</surname><given-names>J.-P.</given-names></name></person-group>, 
<article-title>Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1</article-title>. <source>J. Gen. Virol.</source>
<volume>93</volume>, 
<fpage>2646</fpage>&#x02013;<lpage>2651</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22993189</pub-id></mixed-citation></ref><ref id="R54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porath</surname><given-names>H. T.</given-names></name>, <name name-style="western"><surname>Carmi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Levanon</surname><given-names>E. Y.</given-names></name></person-group>, 
<article-title>A genome-wide map of hyper-edited RNA reveals numerous new sites</article-title>. <source>Nat. Commun.</source>
<volume>5</volume>, 
<fpage>4726</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25158696</pub-id></mixed-citation></ref><ref id="R55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chester</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Somasekaram</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Tzimina</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jarmuz</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gisbourne</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>O&#x02019;Keefe</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Navaratnam</surname><given-names>N.</given-names></name></person-group>, 
<article-title>The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay</article-title>. <source>EMBO J.</source>
<volume>22</volume>, 
<fpage>3971</fpage>&#x02013;<lpage>3982</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12881431</pub-id></mixed-citation></ref><ref id="R56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Patnaik</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Kemer</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Baysal</surname><given-names>B. E.</given-names></name></person-group>, 
<article-title>Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes</article-title>. <source>RNA Biol.</source>
<volume>14</volume>, 
<fpage>603</fpage>&#x02013;<lpage>610</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">27149507</pub-id></mixed-citation></ref><ref id="R57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kidd</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Newman</surname><given-names>T. L.</given-names></name>, <name name-style="western"><surname>Tuzun</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kaul</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Eichler</surname><given-names>E. E.</given-names></name></person-group>, 
<article-title>Population stratification of a common <italic>APOBEC</italic> gene deletion polymorphism</article-title>. <source>PLOS Genet.</source>
<volume>3</volume>, 
<fpage>e63</fpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17447845</pub-id></mixed-citation></ref><ref id="R58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Delahanty</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y.-T.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>Y.-B.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>B.-T.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>X.-O.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>W.</given-names></name></person-group>, 
<article-title>A common deletion in the <italic>APOBEC3</italic> genes and breast cancer risk</article-title>. <source>J. Natl. Cancer Inst.</source>
<volume>105</volume>, 
<fpage>573</fpage>&#x02013;<lpage>579</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23411593</pub-id></mixed-citation></ref><ref id="R59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolger</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Lohse</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Usadel</surname><given-names>B.</given-names></name></person-group>, 
<article-title>Trimmomatic: A flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source>
<volume>30</volume>, 
<fpage>2114</fpage>&#x02013;<lpage>2120</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24695404</pub-id></mixed-citation></ref><ref id="R60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Durbin</surname><given-names>R.</given-names></name></person-group>, 
<article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>. <source>Bioinformatics</source>
<volume>25</volume>, 
<fpage>1754</fpage>&#x02013;<lpage>1760</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19451168</pub-id></mixed-citation></ref><ref id="R61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Handsaker</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wysoker</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fennell</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ruan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Homer</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Marth</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Abecasis</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Durbin</surname><given-names>R.</given-names></name>; <collab>1000 Genome Project Data Processing Subgroup</collab></person-group>, 
<article-title>The sequence alignment/map format and SAMtools</article-title>. <source>Bioinformatics</source>
<volume>25</volume>, 
<fpage>2078</fpage>&#x02013;<lpage>2079</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation></ref><ref id="R62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okonechnikov</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Conesa</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Garc&#x000ed;a-Alcalde</surname><given-names>F.</given-names></name></person-group>, 
<article-title>Qualimap 2: Advanced multi-sample quality control for high-throughput sequencing data</article-title>. <source>Bioinformatics</source>
<volume>32</volume>, 
<fpage>292</fpage>&#x02013;<lpage>294</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26428292</pub-id></mixed-citation></ref><ref id="R63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawrence</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Pag&#x000e8;s</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Aboyoun</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Carlson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gentleman</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>M. T.</given-names></name>, <name name-style="western"><surname>Carey</surname><given-names>V. J.</given-names></name></person-group>, 
<article-title>Software for computing and annotating genomic ranges</article-title>. <source>PLOS Comput. Biol.</source>
<volume>9</volume>, 
<fpage>e1003118</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23950696</pub-id></mixed-citation></ref><ref id="R64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edgar</surname><given-names>R. C.</given-names></name></person-group>, 
<article-title>MUSCLE: Multiple sequence alignment with high accuracy and high throughput</article-title>. <source>Nucleic Acids Res.</source>
<volume>32</volume>, 
<fpage>1792</fpage>&#x02013;<lpage>1797</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15034147</pub-id></mixed-citation></ref></ref-list></back></article>